Portfolio

Abre offers data-as-a-service for K-12 schools by gathering information across disparate software systems and working with administrators and other stakeholders to easily view pertinent data by student, class, school, and district. Supporting the whole child through their learning community and beyond, this platform makes accessing the right data simple and flexible.

ActionStreamer offers a comprehensive software and hardware solution for streaming video and data in sports, defense, and telecommunications. Protected by a robust patent suite, ActionStreamer's technology enables high-definition video, audio, and other data to be transmitted from wearable and other small form factor cameras and devices directly to 5G with low latency and full synchronization, all without the need for a relay station. In addition, ActionStreamer offers custom-designed wearables to meet highly stringent requirements for military and sports applications.

Aerpio Therapeutics is a clinical‐stage biopharmaceutical company focused on advancing innovative therapies and treatments for ocular diseases. Aerpio is a leader in the development of Razuprotafib, a small molecule drug based on Tie2 activation, whose primary treatment is open-angle glaucoma. (NASDAQ:ARPO)

Ahalogy is a platform that combines category trend data, influencer networks, and social optimizing software to drive ROI. Ahalogy was acquired by Quotient in 2018, combining its award-winning social capability with Quotient’s digital out-of-home (DOOH), display, and retailer performance media to create an omnichannel solution that enables advertisers and retailers to engage consumers through purchase. (NYSE: QUOT)

Airway Therapeutics is developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases. Through a unique protein therapy developed to prevent and treat lung diseases, Airway helps treat lung diseases in the most vulnerable patients, including premature infants.

Akebia Therapeutics is a fully integrated biopharmaceutical company that works to address the complications of kidney disease that affect nearly 37 million Americans. Akebia has a commercially available medicine and a late-stage oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), Vadadustat, that is based on Nobel Prize-winning science. (NASDAQ: AKBA) IPO 2014

Amify delivers premium, full-scale Amazon solutions to take company growth to the next level. Through comprehensive, turnkey software specifically built for brands, using the latest data analytics, machine learning, and artificial intelligence technologies to provide unparalleled insights into Amazon's performance. Amify is an end-to-end solution for all things Amazon.

Armatus Bio is a pharmaceutical firm developing precision therapeutics based on genetic science and bioengineering to efficiently and effectively deliver life-saving drugs. With the mission of combining breakthrough science and the rigor of engineering innovation, Armatus Bio delivers real impact for patients. Initial applications provide neuromuscular gene therapy treatments.

Rebranded as Myriad Neuroscience, Assurex Health's personalized pharmacogenomics help doctors determine genetically appropriate medication(s) for patients with neuropsychiatric disorders and other neuro-related medical conditions such as Major Depressive Disorder. Assurex Health was acquired by Myriad Genetics (NASDAQ: MYGN) in 2016.

Astronomer puts developers first and makes it easy to run Apache Airflow to orchestrate and move data with lower overhead and higher reliability. Built for teams who can't risk data downtime, Astronomer is built to unlock developer productivity and supercharge data maturity. Running on the cloud of choice, Astro manages Airflow to allow the focus to be on what really matters: the data.

Beanstalk is a financial technology company that provides a platform that enables merchant organizations to integrate emerging payment routing technologies into their payments stack to lower transaction costs and optimize authorization rates. Beanstalk was acquired by Payroc World Access in 2021.

Blue Ash Therapeutics develops cardiovascular drugs including bringing Azimilide to market. Blue Ash Therapeutics was acquired by Forest Laboratories in 2011 (NYSE: FRX)

Clarigent Health is a pioneering platform that harnesses the power of artificial intelligence and natural language processing to offer clinical decision support for mental health professionals. Patients engage in a five-minute series of questions over any smartphone or tablet with the platform detecting and alerting for potential mental health risks; the first application is to ideation for suicide.

Cordata is a software platform that bridges the intersection between individuals, providers, and high-risk communities, allowing them to have better access to treatment and support. Focused on child welfare, community response, and healthcare navigation, Cordata allows first responders, healthcare, social workers, and counselors to see the person as a whole to develop, implement, and monitor a tailored treatment plan for the individual.

Eikonoklastes is an early-stage biopharmaceutical company focused on rapidly advancing innovative medicines for numerous areas of significant unmet medical need, starting with neurodegenerative diseases and cancers. Their first two programs are focused on gene therapy for Lou Gehrig's Disease (ALS) and immunotherapy for angiogenic-dependent disease, beginning with triple-negative breast cancer.

Enable Injections develops and manufactures on-body delivery systems designed to improve the patient experience by examining the relationships between humans and the systems with which they interact. Enable Injections is redefining the injectable therapy drug delivery for the benefit of patients, providers, payers, and partners.

Eyas Medical Imaging is revolutionizing neonatal care with cutting-edge Ascent (3T), a 3 Tesla MR imaging device — A 3 Tesla magnet offers precise visualization of vital organs like the brain, lungs, heart, and abdomen. This breakthrough is set to empower doctors with unparalleled diagnostic accuracy, leading to better-informed decisions and improved outcomes for infants. While the Ascent (TM) is not yet cleared by the U.S. Food and Drug Administration (FDA) for commercial use in the United States, Eyas has selected Cincinnati Children’s to conduct research studies involving the Ascent (3T) Neonatal MRI System.

Genetesis is building a better standard of care by pioneering the CardioFlux, a medical device revolutionizing the world of healthcare by creating a diagnostic magnetocardiography (MCG) imaging platform, an imaging solution for non-invasive cardiologists to detect both epicardial and microvascular dysfunction in a single test far earlier and faster than ever before.

Hive Networks' technology enables the formation of intelligent networks in healthcare where communities of patients, clinicians, and researchers come together to generate, validate, implement, and disseminate knowledge for improved patient care. Their three-module platform facilitates collaboration in a secure environment for accelerated testing and improved outcomes.

Ilesfay is a technology firm providing cloud-based replication and data delivery solutions for corporate product lifecycle management. Their patented MatchMatching (R) software is utilized to create differencing techniques that dramatically reduce bandwidth requirements and increase replication speed. Ilesfay was acquired by Autodesk in 2014. (NASDAQ: ADSK)

IncludeHealth is a software platform that enables clinicians and patients to extend physical therapy care beyond the clinic. This digital platform for musculoskeletal (MSK) providers allows for the delivery of hybrid care through smartphones, tablets, or laptops. With IncludeHealth there is personalized, measured care that can be delivered through a variety of devices that bolster patient outcomes.

Invirsa is a pharmaceutical company developing drugs that treat eye diseases including viral conjunctivitis (pink eye), dry eye disease, and Fuchs dystrophy (corneal swelling.) Invirsa's lead compound INV 102, aims to quickly and predictably augment the body's response to DNA damage, greatly improving cell stability at the most critical moment.

Jersey Watch is an all-in-one platform that's portfolio of tools connects coaches, parents, and athletes, saving you time during the season. Jersey Watch allows you to build a website, manage registration, and send event notifications and gives you the ability to schedule events, run background checks, and increase donations to help with sports organization growth. Jersey Watch was acquired by a private investor in 2020.

Kurome® Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms. Since inception, over 1600+ compounds have been synthesized, showing significant improvements in key features of the treatment of hematological cancers.

LISNR's Radius SDK enables proximity verification & contactless transactions, including offline data transmission, for payments and financial service providers, merchants, mobility companies, and other proximity applications worldwide. Lisnr's products include Radius, a platform that consists of 3 core optimizations to deliver close-, mid-, or long-range transmissions.

Losant is a comprehensive suite of tools that provide a low-code software platform for their Internet of Things (IOT). The suite of tools allows users to easily connect, visualize, and automate devices and data, leading to real-time sights and actionable intelligence allowing developers to build complex, connection solutions quickly and easily at large scale.

Myonexus Therapeutics is a clinical-stage gene therapy company developing and pioneering corrective treatments for limb-girdle muscular dystrophies. Myonexus Therapeutics was acquired by Sarepta Therapeutics in 2019. (NASDAQ: SRPT)

Nano Detection Technology's universal detection system accurately detects antibiotic-resistant staph bacteria and other pathogens at a faster pace and lower cost than typical manual cultures. NDT's exclusive Biochip IP is the core of their unique biosensor system allowing them to be at the forefront of providing tremendous positive impact in crucial areas of healthcare, including antibiotic stewardship, length of stay, and patient satisfaction.

Navistone improves direct mail marketing productivity by adding the power of intent-recent digital browsing behavior as a planning variable. Navistone allows companies to break through the digital clutter and offset the loss of third-party cookies, improve the overall cost to acquire new customers and avoid the unstable costs of digital advertising while maximizing the investment made to drive site traffic.

Neucore Bio is a leader in the development of precision genetic medicines to improve the lives of patients and their families. Our advanced non-viral genetic medicine platform sets a new standard to address the limitations of viral delivery systems in use today. With its pioneering non-viral approach, Neucore is positioned to reshape the landscape of current genetic medicine treatment protocols, offering unparalleled accuracy and safety, and transformative benefits for individuals confronting untreatable conditions.

Peerro is a job search and career-building application for young individuals who aren't in college or training, but seeking employment and looking to build their future. Peerro gives users the tools they need to create the future they want. Peerro brings together employers, educators, and advocates to find a job, but also showcase their skills while providing resources to help land the job.

ReadySet Surgical's inventory management platform helps hospitals manage their surgical supply chain with proactive surgical case coordination and loaner tray management solutions. This innovative platform provides actionable analytics, and proactive identification of non-compliant inventory requests, eliminates unapproved, off-contract purchasing, and automates "bill-only" validations against item masters ultimately showing the hard dollar ROI quickly after implementation.

Roadtrippers is the #1 road trip planning tool, with more than 25 million trips planned to date covering more than 16.9 billion miles. Roadtrippers is a travel app and content provider that lets travelers discover independently owned points of interest in the United States and Canada. Roadtrippers was acquired by TH2 in 2018.

Sirrus Inc. has patented unique sustainable, energy-efficient processes for the next generation of high-performance coatings, adhesives, sealants, and composites. Sirrus works with development partners in the automotive, electronics, packaging, and consumer goods industries to deliver sustainable products that will enhance energy efficiency, safety, and performance. Sirrus was acquired by Nippon Shokubai in 2017.

SNO Bio is a pharmaceutical company that's developing novel therapeutics that target enzymes associated with s-nitrosylation. In their current pipeline, they are leading two types of drugs that would be targeted at microvascular conditions, tissue oxygenation, and acute kidney injury.

STACK is cloud-based construction software for contractors saving time, increasing accuracy, and improving collaboration from bid decision to project closeout. Contractors use STACK’s cloud-based software to help run their business and maximize their profits, by enabling fast and accurate bid management, takeoff, and estimating, all powered in real-time.

Standard Bariatrics is solving key problems in the number one bariatric procedure, the sleeve gastrectomy, by creating instruments that help surgeons standardize their technique to yield predictable results. Standard Bariatrics was acquired by Teleflex in 2022. (NYSE: TFX)

StreamSpot offers a comprehensive suite of hardware and software to allow for the turn-key implementation of streaming video. Their automated workflow and intuitive interface make it easy for anyone to schedule and coordinate the streaming of any event. Streamspot was acquired by Subsplash in 2020.

Talmetrix brings the human approach to data and insights for employee feedback. Thoughtfully designed to delve into the core of your organization, shedding light on critical aspects such as intent to stay, climate, culture, equity, and inclusion. This powerful insight tool empowers you to understand, measure, and strengthen your organization.

Team Central is the next generation in automation technology that pairs a low/no-code integration platform optimizing productivity through improvements in how data is managed and governed across business systems.

Tembo is the Postgres developer platform for building every data service. Their mission is to collapse the database sprawl of the modern data stack with a unified developer platform. With Tembo, developers can quickly create and deploy specialized data services using Stacks, pre-built Postgres configurations, and deployments without complex builds or additional data teams.

Voxel is an artificial intelligence-based software platform that automates the design of parts made with additive manufacturing (3D printing). Engineers input detailed design parameters and test requirements, with the AI platform generating designs meeting all of the parameters and requirements, eliminating guesswork and multiple iterations of design - test - redesign required in current practice.

Vurvey software enables faster, easier, and more dynamic ideation tools for product teams by bringing all creative assets together in one place. Whiteboards are temporary and messy. Vurvey's platform is powered by boards, cards, and collaboration. From ideas and trends, through alignment on team thoughts and collaboration, Vurvey allows product teams to visualize 3D concepts and mood boards while keeping teams organized and integrating assignments and task lists.

Workflex Solutions software helps call centers adjust to demands in real-time for more efficient operations, better customer service, and great employee satisfaction. Workflex Solutions was acquired by Nice, Ltd. in 2017. (NASDAQ: NICE)

XII Medical is a health technology company revolutionizing the treatment of obstructive sleep apnea.